The data establish the first clinical proof-of-mechanism for RNA activation (RNAa) in a human monogenic disease, ...

Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that ...

Lonza, the world's leading contract development and manufacturing organization (CDMO), and Asimov, the company building an AI ...

Agreement links medicine affordability with continued innovation as Astellas commits to internationally aligned pricing for future therapies and donates 25 kg of tacrolimus API to the US Strategic ...

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...

AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in ...

Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...

First-in-human study evaluates dual-target, dual-payload ADC in advanced ovarian cancer and other solid tumours Phrontline ...

Sixty-four discontinued programmes, withdrawn filings, lapsed deals and missed dates from Asia-Pacific sponsors, each one sourced to the sponsor's own disclosure. Most of them came with a strategy, ...

Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the ...

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...